meRfi®-GM
Adiposity / Obesity & Childhood / Child
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
In the United States, children have an elevated intake of saturated fats () and a high percentage of therapeutic antibiotic usage (). However, how concurrent exposure to an High-fat diet (HFD) and antibiotics alters the risk for childhood obesity remains unknown.
An obesogenic Western-style HF diet perturbs the microbiota and elevates the risk for [metabolic diseases](brain://gaettDKt71SDbucTVdunyA/MetabolicDiseasesMetabolicDisorders…
References (Sources)
- An early-life microbiota metabolite protects against obesity by regulating intestinal lipid metabolism
- Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome
- Fighting Fatty Liver Diseases with Nutritional Interventions, Probiotics, Symbiotics, and Fecal Microbiota Transplantation (FMT)
- High-fat diet-induced colonocyte dysfunction escalates microbiotaderived trimethylamine N-oxide
- Implication of gut microbiota in the association between infant antibiotic exposure and childhood adiposity/obesity and adiposity accumulation
- Outpatient antibiotic use and the need for increased antibiotic stewardship efforts
- Randomised clinical trial: The beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis